| 发明名称 |
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE |
| 摘要 |
The present invention relates to use of an inhibitor of the renin- angiotensin system (RAS) or a pharmaceutically acceptable derivative thereof, particularly ramipril or ramiprilat, in the manufacture of a medicament for the prevention of stroke, diabetes and/or congestive heart failure (CHF). The present invention further relates to a method of prevention and/or treatment of stroke, diabetes and/or CHF, comprising administering a therapeutically effective amount of an inhibitor of the RAS or a pharmaceutically acceptable derivative thereof, particularly ramipril or ramiprilat, to a patient in need of such prevention and/or treatment. |
| 申请公布号 |
KR20080035703(A) |
申请公布日期 |
2008.04.23 |
| 申请号 |
KR20087007837 |
申请日期 |
2008.03.31 |
| 申请人 |
SANOFI-AVENTIS DEUTSCHLAND GMBH |
发明人 |
SCHOELKENS BERNWARD;BENDER NORBERT;RANGOONWALA BADRUDIN;DAGENAIS GILLES;GERSTEIN HERTZEL;LJUNGGREN ANDERS;YUSUF SALIM |
| 分类号 |
A61K31/40;A61K45/00;A61K31/00;A61K31/357;A61K31/401;A61K31/4025;A61K31/403;A61K31/404;A61K31/41;A61K31/4166;A61K31/4178;A61K31/4184;A61K31/435;A61K31/497;A61K31/519;A61K31/55;A61K31/551;A61K31/554;A61P3/10;A61P9/02;A61P9/04;A61P9/10;A61P25/28;A61P43/00;C07D209/52 |
主分类号 |
A61K31/40 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
